Clinical experiment of mutant herpes simplex virus HF10 therapy for cancer.
Nakao A, Takeda S, Shimoyama S, Kasuya H, Kimata H, Teshigahara O, Sawaki M, Kikumori T, Kodera Y, Nagasaka T, Goshima F, Nishiyama Y, Imai T.
Nakao A, et al. Among authors: kimata h.
Curr Cancer Drug Targets. 2007 Mar;7(2):169-74. doi: 10.2174/156800907780058808.
Curr Cancer Drug Targets. 2007.
PMID: 17346108
Clinical Trial.